Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. PolyPeptide Group AG
  6. Summary
    PPGN   CH1110760852

POLYPEPTIDE GROUP AG

(PPGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
126.8(c) 130(c) 125.8(c) 124.8(c) 125.8(c) Last
42 956 34 020 15 847 14 413 63 072 Volume
-7.04% +2.52% -3.23% -0.79% +0.80% Change
More quotes
Estimated financial data (e)
Sales 2021 280 M 328 M 328 M
Net income 2021 52,5 M 61,6 M 61,6 M
Net cash position 2021 146 M 172 M 172 M
P/E ratio 2021 61,3x
Yield 2021 0,17%
Sales 2022 318 M 373 M 373 M
Net income 2022 60,1 M 70,5 M 70,5 M
Net cash position 2022 145 M 170 M 170 M
P/E ratio 2022 63,3x
Yield 2022 0,36%
Capitalization 3 799 M 4 464 M 4 455 M
EV / Sales 2021 13,1x
EV / Sales 2022 11,5x
Nbr of Employees 1 026
Free-Float 31,3%
More Financials
Company
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. 
More about the company
All news about POLYPEPTIDE GROUP AG
09/06ANALYST RECOMMENDATIONS : Asos, Best Buy, Docusign, Greif, Hewlett Packard...
08/17EQS-ADHOC : PolyPeptide reports strong H1 2021 -2-
DJ
08/17EQS-ADHOC : PolyPeptide reports strong H1 2021 revenue growth and operating leve..
DJ
08/17PolyPeptide Group AG Revises Earnings Guidance for the Full Year of 2021
CI
08/17PolyPeptide Group AG Reports Earnings Results for the First Half of 2021
CI
06/25POLYPEPTIDE : appoints Christina Del Vecchio as General Counsel and member of th..
EQ
06/25PolyPeptide Group AG Appoints Christina Del Vecchio as General Counsel and Me..
CI
05/12Montana Aerospace shares soar on Swiss stock market debut
RE
05/10POLYPEPTIDE GROUP AG(SWX : PPGN) added to Swiss Performance Index (Price Return)
CI
05/06GLOBAL MARKETS LIVE : Uber, AB Inbev, PayPal...
05/06POLYPEPTIDE : Overallotment Option Taken In Full In Swiss IPO
MT
05/05EQS-ADHOC : PolyPeptide Group announces the -2-
DJ
05/05POLYPEPTIDE : announces the exercise of the full over-allotment option
EQ
04/29PolyPeptide Group AG has completed an IPO in the amount of CHF 737.39136 mill..
CI
04/22PolyPeptide Group Mulls Non-Organic Growth Opportunities
CI
More news
News in other languages on POLYPEPTIDE GROUP AG
09/13MADRID STOCK EXCHANGE : Los mercados se quedan sin combustible
09/13STOCK MARKET PARIS : Des marchés en panne de carburant
09/13AVIS D'ANALYSTES DU JOUR : BMW, Allianz, Getlink, Ubisoft, Neoen, Polypeptide, V..
09/06MADRID STOCK EXCHANGE : ¿Qué hacemos ahora?
09/06STOCK MARKET PARIS : Qu'est-ce qu'on fait maintenant ?
More news
Analyst Recommendations on POLYPEPTIDE GROUP AG
More recommendations
Chart POLYPEPTIDE GROUP AG
Duration : Period :
PolyPeptide Group AG Technical Analysis Chart | PPGN | CH1110760852 | MarketScreener
Technical analysis trends POLYPEPTIDE GROUP AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 115,02 €
Average target price 132,16 €
Spread / Average Target 14,9%
EPS Revisions
Managers and Directors
Raymond de Vre Chief Executive Officer
Jan Fuhr Miller Chief Financial Officer
Peter Wilden Chairman
Daniel Lasanow Director-Global Operations
Beat In-Albon Independent Director
Sector and Competitors
1st jan.Capi. (M$)
POLYPEPTIDE GROUP AG0.00%4 464
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420